![Laura Williams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 31/07/2026
Laura A. Williams is Chief Patient Officer at Ardelyx, Inc. since 2025.
Formerly, Dr. Williams was Independent Director at Imara, Inc. from 2021 to 2023, Senior Vice President-Clinical Development at AMAG Pharmaceuticals, Inc. from 2017 to 2020, and Vice President-Clinical Development at Myovant Sciences, Inc. from 2016 to 2017.
Education includes graduate studies at the University of Washington, undergraduate studies at Mississippi State University, and a doctorate from the University of Iowa.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ARDELYX, INC. 0,15 % | 18/06/2026 | 378.195 ( 0,15 % ) | 2 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ARDELYX, INC. | Corporate Officer/Principal | 01/01/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| IMARA | Director/Miembro de la Junta | 01/02/2023 |
| AMAG PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/01/2020 |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Director Técnico/Científico/I+D | 01/08/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mississippi State University
 Mississippi State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes novel therapeutics for patients with sickle cell disease | Health Technology |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
